Literature DB >> 14668261

Colistin interactions with the mammalian urothelium.

Jamie R Lewis1, Simon A Lewis.   

Abstract

Here we describe the effect of colistin on the barrier function of the mammalian urinary bladder epithelium. Addition of colistin to the mucosal solution of the rabbit urinary bladder epithelium (urothelium) resulted in an increase in the transepithelial conductance. The magnitude of the increase in transepithelial conductance was dependent on the membrane voltage, concentration of colistin, and presence of divalent cations in the bath solution. The initial site of action of colistin was at the apical membrane. Colistin increased the membrane conductance only when the apical membrane potential was cell interior negative. The more negative the membrane potential, the larger the conductance increase. The concentration dependence of the conductance increase saturated, suggesting a membrane binding site. Divalent cations decreased the magnitude of the conductance increase. This divalent cation action occurred at two sites: one in competition with colistin for a membrane binding site, and the other by rapidly blocking the induced conductance. At short exposure times, the increase in conductance was reversed by either removing colistin from the bath or changing the voltage so that the apical membrane was cell interior positive. At long exposure times, the increase was only partially reversible by voltage or removal from the bath. This finding suggests that at long exposure times, there is a toxic effect of colistin on the urothelium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668261     DOI: 10.1152/ajpcell.00437.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  16 in total

Review 1.  The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.

Authors:  Matthew E Falagas; Sofia K Kasiakou; Sotirios Tsiodras; Argyris Michalopoulos
Journal:  Clin Med Res       Date:  2006-06

2.  Colistin and rhabdomyolysis: a causative agent or an innocent bystander?

Authors:  Penelope Evagelopoulou; Andreas Katsaros; Pavlos Myrianthefs; Stylianos Karatzas; Eleni Boutzouka; George Fildissis; George Baltopoulos
Journal:  Intensive Care Med       Date:  2007-01-20       Impact factor: 17.440

Review 3.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

4.  Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model.

Authors:  Phillip J Bergen; Jurgen B Bulitta; Alan Forrest; Brian T Tsuji; Jian Li; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

5.  Efficacy and Safety of Intravenous Colistin in Very Low Birth Weight Preterm Infants.

Authors:  Ozkan Ilhan; Meltem Bor; Senem Alkan Ozdemir; Sinem Akbay; Esra Arun Ozer
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

Review 6.  Colistin in the 21st century.

Authors:  Roger L Nation; Jian Li
Journal:  Curr Opin Infect Dis       Date:  2009-12       Impact factor: 4.915

7.  Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Craig R Rayner; David Taylor; Deborah Middleton; Robert W Milne; Kingsley Coulthard; John D Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

8.  Renal and neurological side effects of colistin in critically ill patients.

Authors:  Herbert Spapen; Rita Jacobs; Viola Van Gorp; Joris Troubleyn; Patrick M Honoré
Journal:  Ann Intensive Care       Date:  2011-05-25       Impact factor: 6.925

9.  Antibacterial susceptibility patterns and cross-resistance of acinetobacter, isolated from hospitalized patients, southern iran.

Authors:  S Japoni; S Farshad; A Abdi Ali; A Japoni
Journal:  Iran Red Crescent Med J       Date:  2011-11-01       Impact factor: 0.611

10.  High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

Authors:  Lidia Dalfino; Filomena Puntillo; Adriana Mosca; Rosa Monno; Maria Luigia Spada; Sara Coppolecchia; Giuseppe Miragliotta; Francesco Bruno; Nicola Brienza
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.